Embera NeuroTherapeutics, Inc.
BioSpace1, 2031 Kings Highway
Shreveport, LA 71103
Embera NeuroTherapeutics, Inc. is a development stage, pharmaceutical company focused on novel treatments for a broad range of addictions and obesity - both significant, growing problems in the United States and worldwide with limited effective drug therapies. Our initial product in development, EMB-001, is a patent-pending combination of two off-patent, FDA-approved drugs, to stop the cravings and loss of control related to substance abuse. The technology is based on the scientific founder Dr. Nick Goeders' work at Louisiana State University Health Sciences Center (LSUHSC-S) on the role of physiologic responses to chronic stress in addiction. Embera believes that this technology, which focuses on breaking the neural pathways related to cravings, represents a breakthrough in the treatment of substance abuse and food craving related to obesity. Treatments that break these barriers to recovery would be significant contributions to the treatment of drug addiction.
